Navigation Links
Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis
Date:7/23/2009

tory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

    Contact: Raul Rodriguez
    Phone: 650.624.1302
    Email: invrel@rigel.com

    Media Contact: Susan C. Rogers, Alchemy Consulting, Inc.
    Phone: 650.430.3777
    Email: susan@alchemyemail.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Rigel to Present at Jefferies Healthcare Conference
2. Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers
3. Rigel to Present at JMP Securities Research Conference
4. Rigel to Present at Barclays Capital Healthcare Conference
5. Rigel Announces Fourth Quarter and Year End 2008 Financial Results
6. Rigel to Present at BIO CEO & Investor Conference
7. Rigel to Host Conference Call on February 3, 2009
8. Rigel to Present at Keystone Symposia Conference
9. Phase 2 Results of Rigels R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL
10. Rigel to Present at the Piper Jaffray Annual Health Care Conference
11. Rigel to Present at the Oppenheimer 19th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... thinks it,s as short as 34 weeks, potentially add... , FRIDAY, Nov. 20 (HealthDay News) -- Recent r...ntinues to climb in the United States. Now, a new...fused about what constitutes a full-term birth in ...hers surveyed in the study considered a baby born ...
(Date:11/20/2009)...lu activity remains high and is expected to contin...thDay News) -- Some areas of the United States are...eral health official said Friday, and while the di... from the 46 states reported last week. , "We a...ivity around the country, but there is still a lot...
(Date:11/20/2009)..., SPRINGFIELD, Mo., Nov. 20 Mis...entral Missouri regions will now have the option t... reached Tuesday between Missouri Consolidated Hea..., The Southwest and South Central Missouri regions...dar, Christian, Dade, Dallas, Douglas, Greene, Hic...
(Date:11/20/2009)..., BATON ROUGE, La., Nov. 20 /PRNewswire-USNew...ans (LAHP) today warned that Louisianians could ex...enefits if proposals being considered by Congress ...hief executive officer for LAHP, "Louisiana health...form since the beginning of the national debate. ...
(Date:11/20/2009)..., LANSING, Mich., Nov. 20 /PRNewswire-USNewswir...n seven Americans struggled to get enough food to ...iculties of older adults who are rapidly aging int...death of a spouse or divorce mean many have income... housing and medicine. Older women are particular...
Breaking Medicine News(10 mins):Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2
...ndividual’s specific tumor type prior to surgery c...t of patients diagnosed with kidney cancer.// A ne... Positron Emission Tomography (PET) using a radiol... the urologist with crucial information that will ...
...g the inmates of Tihar Jail in the national capita... an official report// said here Thursday. In...sease as compared to 12 in 2002, Minister of State...stration to rule out any possibility of spreading ...
...te, a world-renowned California-based biomedical f...ve come up with a chemical// that would help preve... The synthetic compound, called MTIP, blocks t...s, as revealed in the Journal of Neuroscience, sho...
...aylight savings time starts 3 weeks earlier than u...us// one is the probable malfunctioning of medical... Health Canada has issued warnings not only to ind...ies voice their concern about the effect on day li...
...as been reported in a duck farm in Chonan, in cent...as confirmed as bird flu on Thursday//. The cause ...rus. It is the seventh bird flu outbreak sin...gin shortly within the 3-kilometer (2-mile) radius...
...er spends increasingly more time in a pub are ofte...olic? // It's a real issue for many people, m...ird party in their relationship and are often comp...ings, and that can put a great deal of strain on t...
Other Medicine News:Health News:PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery 2Health News:PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery 3Health News:Partners of Alcoholics May Need to Seek help 2
(Date:11/19/2009)...re-FirstCall/ -- In a series of new initiatives to...ion (Nasdaq: HSKA ) ("Heska" or the "Company") an...ebsite. The upgraded site is the result of severa...ign the site with the company,s new brand image an....newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...
(Date:11/19/2009)...ire-FirstCall/ -- The D e al magazine has name... Corporate Dealmakers for the second consecutive y...d Dealmaker in pharma/biotech for the most effecti...since January 2006. ,, Over the past decade, Ab...cus on high-growth, innovation-driven businesses w...
(Date:11/19/2009)...ire/ -- Mach 7 Technologies, a global provider o...nt solutions, and QStar Technologies have signed a...chive solution through their common US distributio...der in providing digital image distribution and ar...the agreement, Data Distributing will be able to p...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4The power of prayer 3F 49285 1The power of prayer 3F 49285 2Innovative Voice and Swallowing Center Opens in Orange County 49283 1Innovative Voice and Swallowing Center Opens in Orange County 49283 2Innovative Voice and Swallowing Center Opens in Orange County 49283 3Imagenetix Inc Reports Year End Results 49281 1Imagenetix Inc Reports Year End Results 49281 2Imagenetix Inc Reports Year End Results 49281 3Imagenetix Inc Reports Year End Results 49281 4Imagenetix Inc Reports Year End Results 49281 5
...INGSTOKE, England and CAMBRIDGE Massachusetts, Jul...ogy company, Jerini AG for an equity purchase pri... (HAE) product, FIRAZYR(R), to its Human Genetic T...lobal sales expected to be around $350-400 millio... environment, - Expected to be accretive for Non ...
...mission of Five-Day Dosing Regimen sNDA Targeted f... 2008, WOODCLIFF LAKE, N.J., July 1, 2008 Eisai...preliminary efficacy data from a trial,initiated i...upportive Care,(BSC) in elderly patients with myel...nstrate a statistically significant advantage of D...
Other Medicine Technology:Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4
...ed ergonomics for today's exacting laboratory rout...est and the large display windows enhance operator... feature soft-touch tip ejection with power-booste...t for 0.2 - 50ul micro volume pipetting. For absol...
Eppendorf Research Series 2100 Adjustable-volume Pipette
Sysmex KX-21N Automated Hematology Analyzer
...atures several of the most advanced and truly auto...Offering an unparalleled combination of automated ...ilds on the popular and proven Affinity pacemakers...entricular AutoCapture Pacing Systems, assuring Be...
Medicine Products: